S&P 500
5,278.40
▲
+0.45%
NASDAQ
16,755.02
▲
+0.67%
DOW JONES
38,886.57
▲
+0.32%
RUSSELL 2000
2,084.45
▲
+0.15%
VIX
13.42
▼
-1.52%
GOLD
2,348.30
▲
+0.21%
OIL (WTI)
78.62
▲
+0.18%
US 10Y
4.28%
▼
-0.04%
S&P 500
5,278.40
▲
+0.45%
NASDAQ
16,755.02
▲
+0.67%
DOW JONES
38,886.57
▲
+0.32%
RUSSELL 2000
2,084.45
▲
+0.15%
VIX
13.42
▼
-1.52%
GOLD
2,348.30
▲
+0.21%
OIL (WTI)
78.62
▲
+0.18%
US 10Y
4.28%
▼
-0.04%
(RTTNews) – Thursday, Prenetics Global Limited (PRE) announced the appointment of Brian Rosin as U.S. Chief Financial Officer, leading the company’s finance organization, IM8.
In his new role, Mr. Rosin will be responsible for financial strategy, capital allocation, investor relations support, and the financial infrastructure and unit-economics discipline required to scale a premium consumer health brand from breakout launch to durable, profitable, global category leadership.
Previously, Rosin served as CFO and and Senior Vice President, e-Commerce Operations, of Wellbeam Consumer Health, a private equity-backed e-Commerce-focused consumer wellness platform.
In the pre-market hours, PRE is trading at $17.05, down 2.95 percent on the Nasdaq.
The Insider Newsletter
Markets, decoded — every week.
Signal over noise, in your inbox.
Note.
For informational purposes only. Not financial advice. Past performance does not guarantee future results.
E
About the author
Elena Park
Markets editor · Podcast co-host
Elena leads the Markets desk and co-hosts The Freedom Market Podcast. She writes about monetary policy and markets, focused on how macro turns into investor decisions.
